Aligned Genetics Inc (238120) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.058x

Based on the latest financial reports, Aligned Genetics Inc (238120) has a cash flow conversion efficiency ratio of -0.058x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.04 Billion ≈ $-1.38 Million USD) by net assets (₩35.50 Billion ≈ $24.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 238120 market cap overview for the company's overall valuation and market capitalisation.

Aligned Genetics Inc - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Aligned Genetics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Aligned Genetics Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aligned Genetics Inc ranked by their cash flow conversion efficiency. Explore 238120 cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Jeongsan Aikang Co.Ltd KQ:022220	-0.044x
Karolinska Development AB ser. B ST:KDEV	-0.004x
Centric Holdings S.A AT:CENTR	0.008x
Primary Health Properties LSE:PHP	0.035x
Sung Bo Chem KO:003080	-0.044x
Cobalt Blue Holdings Ltd AU:COB	-0.121x
Rocketboots Ltd AU:ROC	-19893.119x
Guler Yatirim Holding AS IS:GLRYH	0.065x

Annual Cash Flow Conversion Efficiency for Aligned Genetics Inc (2015–2024)

The table below shows the annual cash flow conversion efficiency of Aligned Genetics Inc from 2015 to 2024. View current stock price of Aligned Genetics Inc for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩35.49 Billion ≈ $24.05 Million	₩3.07 Billion ≈ $2.08 Million	0.086x	-5.07%
2023-12-31	₩31.31 Billion ≈ $21.22 Million	₩2.85 Billion ≈ $1.93 Million	0.091x	+18.10%
2022-12-31	₩28.85 Billion ≈ $19.55 Million	₩2.22 Billion ≈ $1.51 Million	0.077x	+1429.28%
2021-12-31	₩26.99 Billion ≈ $18.29 Million	₩135.97 Million ≈ $92.14K	0.005x	+203.10%
2020-12-31	₩21.46 Billion ≈ $14.55 Million	₩35.67 Million ≈ $24.17K	0.002x	-94.71%
2019-12-31	₩20.97 Billion ≈ $14.21 Million	₩659.29 Million ≈ $446.79K	0.031x	+137.58%
2018-12-31	₩20.89 Billion ≈ $14.16 Million	₩-1.75 Billion ≈ $-1.18 Million	-0.084x	-116.08%
2017-12-31	₩22.64 Billion ≈ $15.34 Million	₩-876.75 Million ≈ $-594.16K	-0.039x	+17.86%
2016-12-31	₩24.18 Billion ≈ $16.39 Million	₩-1.14 Billion ≈ $-772.65K	-0.047x	+18.73%
2015-12-31	₩6.06 Billion ≈ $4.11 Million	₩-351.72 Million ≈ $-238.36K	-0.058x	--

About Aligned Genetics Inc

KQ:238120 Korea Medical Devices

Market Cap

$29.34 Million

₩43.30 Billion KRW

Market Cap Rank

#23955 Global

#1679 in Korea

Share Price

₩3080.00

Change (1 day)

+1.48%

52-Week Range

₩2680.00 - ₩6050.00

All Time High

₩7875.00